Dr. Samer Othman Alharthi, MD

Dr. Alharthi practices at Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System.

Dr. Alharthi's NPI, 1093166316, was assigned on June 28, 2016. Dr. Alharthi holds Georgia license 97342.

Dr. Alharthi's primary practice is Northeast Georgia Medical Center Gainesville, at 743 Spring Street, Gainesville, GA 30501 in Hall County. The practice phone is (770) 535-3553.

Dr. Alharthi's primary practice is Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System. Dr. Alharthi is also affiliated with Northeast Georgia Medical Center Habersham. The medical group on file is Northeast Georgia Physicians Group Inpatient Neurology. Dmand AI also links Dr. Alharthi to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alharthi practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Alharthi's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Alharthi's licenses on file in 2 states: Georgia and Virginia.

CMS data shows 1,669 Medicare services from Dr. Alharthi across 25 procedure codes in 2024, for 1,055 Medicare patients. Medicare paid $72,875 for them.

CMS counts 1,055 Medicare patients who saw Dr. Alharthi in 2024. The largest group is 75 to 84, with 414 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alharthi's median patient age at 73, with 49% women.

In 2024, Dr. Alharthi wrote 216 Medicare Part D claims for 76 patients. 82% of them were for generic drugs. CMS names the drug for 174 of them, across 5 drugs with 11 or more claims each, at $32,320 in total drug cost. In 2022, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Alharthi for performance year 2024, reported as part of a group.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Alharthi, published from 2018 to 2021. 2021 was the busiest year, with 3. The most frequent topics are Robotic Surgical Procedures, Hospital Costs and Laparoscopy. Dr. Alharthi has published most often in Am Surg. Dr. Alharthi's most frequent co-authors are Abdulaziz Abdu Arishi, MD, Mohanad Baldawi, MD and Maria Chulkov, MD.

CMS Open Payments shows 100 general payments to Dr. Alharthi from 19 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 42% of the total. Medtronic, Inc. paid the most, $10,508.